Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 17, 2022 10:54 ET | Source: Moore Kuehn

Moore Kuehn Encourages BIOT, VGII, CPTK, and DSAC Investors to Contact Law Firm

NEW YORK, March 17, 2022 (GLOBE NEWSWIRE) -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims...
November 11, 2021 10:15 ET | Source: Moore Kuehn

Moore Kuehn Encourages MNR, DSAC, BIOT, and ZIXI Investors to Contact Law Firm

NEW YORK, Nov. 11, 2021 (GLOBE NEWSWIRE) -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims...
October 01, 2014 02:00 ET | Source: OnCore Biopharma, Inc.

OnCore Biopharma Agrees to Acquire Enantigen Therapeutics

DOYLESTOWN, Pa., Oct. 1, 2014 (GLOBE NEWSWIRE) -- OnCore Biopharma, Inc. ("OnCore" or the "Company"), a biotechnology company focused on the research, development and commercialization of oral...